J. Zhou

Study reveals how NK cell migration affects health in HIV-infected individuals.

MRPC3b development enhances particle detection for future experiments.

Study reveals adaptive CRT improves survival and reduces healthcare costs for heart failure patients.

Study shows metformin may reduce risks of dementia and anxiety in diabetes patients.

Research links DNAH12 mutations to male infertility and sperm defects.

This article explores gauge fixing and its role in understanding DNA and protein functions.

A study on using language models to identify metastatic cancer from clinical notes.

New findings show PIKFYVE inhibition can enhance cancer immunotherapy effectiveness.

Nivolumab shows promise in treatment, but cost-effectiveness raises concerns.

Scientists develop BOOST to speed up sample preparation for clearer imaging.

BEPH enhances cancer detection and survival prediction through innovative image analysis.

Research reveals WTAP's crucial role in regulating immune response via m6A modification.

Study reveals how mutations influence organism fitness and evolutionary biology.

Study reveals how prenatal famine affects metabolic health and disease risk.

ATG6 and NPR1 work together to strengthen plant defenses against disease.

A new method helps distinguish brain signals from noise in neuroscience studies.

Research reveals important roles of m5C modifications in gene expression and disease.

Study reveals a connection between GERD and chronic pain conditions.

Study reveals machine learning models can enhance hospital discharge predictions.

CTAC scans may improve heart health assessments by analyzing body composition.

This study investigates a new approach to alleviate post-surgery pain in lung cancer patients.

Study reveals diabetes drugs may impact prostate cancer risk differently.

Research investigates how electron spins affect helium-4 scattering results.

Researchers enhance language models to better analyze HIV drug resistance studies.

Pyrotinib shows promise in reducing cancer recurrence for high-risk patients.

New insights reveal β-CTF's key role in Alzheimer’s synaptic damage.